Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV
Study Details
Study Description
Brief Summary
The purpose of this study is to determine the effectiveness of a stress management group intervention for people with HIV. The study will evaluate several outcomes, including perceived stress, quality of life, psychosocial factors, and physiological measures of stress.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2 |
Detailed Description
It is well documented that living with HIV/AIDS can cause a great amount of stress, and evidence suggests that stress may hasten HIV disease progression by increasing viral replication and suppressing the immune response. Stress management intervention studies using more complex combinations of cognitive and relaxation therapies have shown improvements in both psychological and physiological measures in HIV infected persons. However, no studies have focused on only one intervention or have addressed the spiritual component using a comparable control group to determine which of these interventions is most effective.
Participants will be randomly assigned to receive either a spiritually-based cognitive intervention to an educational control group. The intervention will be given over a 10-week period, with 5 weekly classes, 4 weekly automated phone calls, and one final class meeting. Assessments will be conducted at pre-intervention, fifth class midpoint, tenth week post-intervention, and 3-month follow-up. Time commitment can vary from 6 months to 9 months, depending on when participants are screened.
Study Design
Outcome Measures
Primary Outcome Measures
- Intrusive Thoughts []
- Perceived Stress []
- Trait Anxiety []
- Trait Anger []
Secondary Outcome Measures
- Spiritual Well-Being (FACIT-SpEx) []
- Quality of Life Enjoyment and Satisfaction []
- Ways of Coping []
- Urinary cortisol levels []
- Urinary catecholamines []
- Salivary cortisol levels []
Eligibility Criteria
Criteria
Inclusion Criteria:
-
HIV infected for at least 6 months
-
Ability to read and write English
Exclusion Criteria:
-
Drug use within the past 6 months
-
Cognitive impairment or dementia
-
Diagnosis that may affect cortisol levels, such as diabetes, cancer, or asthma
-
Loss of family/loved one in past 3 months
-
Started a relaxation therapy in past 3 months
-
History or current practice of the RISE program, rosary, chanting, or Transcendental Meditation (TM)
-
Acute infection in past month
-
Change of HAART or drug regimen in past month
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | VA San Diego Healthcare System | San Diego | California | United States | 92161 |
Sponsors and Collaborators
- National Center for Complementary and Integrative Health (NCCIH)
- University of California, San Diego
Investigators
- Principal Investigator: Jill E. Bormann, PhD, RN, California San Diego Healthcare System
Study Documents (Full-Text)
None provided.More Information
Publications
- R21AT001159-01A1